3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
4
Prostatic Neoplasms
2
Venous Thromboembolism
1
Thrombocythemia, Essential
1
Smoking Cessation
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Ovarian Neoplasms
1
Neoplasms
1
Motor Activity
1
Lung Neoplasms
1
Liver Cirrhosis
1
Leukemia, Hairy Cell
1
Inflammation
1
Hemorrhage
1
Fibrosis
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Carcinoma
1
Breast Neoplasms
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
Cisplatin
11
pembrolizumab
10
Carboplatin
7
Radiotherapy
6
Cetuximab
6
Docetaxel
5
Surveys and Questionnaires
3
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
Cyclophosphamide
3
fludarabine
2
cemiplimab
2
atezolizumab
2
aldesleukin
2
Surgical Procedures, Operative
2
Standard of Care
2
Radiation
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Fluorouracil
2
Drug Therapy
2
vistusertib
1
toripalimab
1
sitravatinib
1
palbociclib
1
osimertinib
1
olaparib
1
niraparib
1
lenvatinib
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Aspirin
×
90 days
×
Clear all
No trials found.